Ronald Mierzwa

952 citations
36 papers · 764 indexed · h-index 18
Topics
Microbial Natural Products and Biosynthesis (14 papers)Antibiotic Resistance in Bacteria (6 papers)Marine Sponges and Natural Products (4 papers)

In The Last Decade

Ronald Mierzwa

35 papers receiving 715 citations

Peers

Ronald Mierzwa
Comparison fields: 5 of 80
  • Molecular Biology 300
  • Pharmacology 288
  • Organic Chemistry 204
  • Biotechnology 162
  • Molecular Medicine 126
Replace Xuefu You with:
Xuefu You China
Yukihiro Asami Japan
Shuyi Si China
Motohiro Hino Japan
Ryuji Marumoto Japan
Stephan Hüttel Germany
Ryo Okachi Japan
Yanan Hu United States
Raimo Franke Germany
Claude G. Lerner United States
Ronald Mierzwa relative to Xuefu You China Xuefu You's profile →
Citations per field
00.5×1.5×2.5×
Xuefu You · 1×
Citations per year

Countries citing papers authored by Ronald Mierzwa

Since Specialization
Citations

This map shows the geographic impact of Ronald Mierzwa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald Mierzwa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald Mierzwa more than expected).

Fields of papers citing papers by Ronald Mierzwa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald Mierzwa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald Mierzwa. The network helps show where Ronald Mierzwa may publish in the future.

Co-authorship network of co-authors of Ronald Mierzwa

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald Mierzwa. A scholar is included among the top collaborators of Ronald Mierzwa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald Mierzwa. Ronald Mierzwa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 23
2 10
3 19
4 0
5 35
6 33
7 7
8 7
9 6
10 14
11 4
12 27
13 29
14 38
15 10
16 8
17 50
18 26
19 2
20 4

About Ronald Mierzwa

Ronald Mierzwa is a scholar working on Molecular Medicine, Pharmacology and Biotechnology, having authored 36 papers that have together received 764 indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (14 papers), Antibiotic Resistance in Bacteria (6 papers) and Marine Sponges and Natural Products (4 papers). The work is most often cited by research in Molecular Medicine (126 citations), Biotechnology (162 citations) and Pharmacology (288 citations). Ronald Mierzwa has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Mahesh Patel, Mohindar S. Puar, Min Chu, Vincent P. Gullo, Joseph Terracciano, Karen Joy Shaw, George H. Miller, R S Hare, Imbi Truumees and Tze‐Ming Chan. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Chromatography A and Applied Microbiology and Biotechnology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026